DOD Biotech PCL
SET:DOD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.65
3.84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DOD Biotech PCL
Total Liabilities & Equity
DOD Biotech PCL
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DOD Biotech PCL
SET:DOD
|
Total Liabilities & Equity
฿1.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Total Liabilities & Equity
฿5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Total Liabilities & Equity
฿2.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Total Liabilities & Equity
฿3B
|
CAGR 3-Years
57%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Total Liabilities & Equity
฿4.6B
|
CAGR 3-Years
45%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Total Liabilities & Equity
฿615m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
DOD Biotech PCL
Glance View
DOD Biotech Public Co., Ltd. is engaged in manufacture of food supplements. The company is headquartered in Samut Sakhon, Samut Sakhon. The company went IPO on 2018-06-20. The firm operates in five segments: supplementary business, manufacturing cosmetics, network marketing business, manufacturing extraction, and others. Its products categories include beauty products, which includes skincare products and dietary supplements; health products include health supplements, and own-branded products under brand Dieto, which is a protein food supplement, help maintain shape Helps reduce the accumulation of excess fat nervous system. The company offers tablet products, such as capsules and flower tablets. The firm provides drinking powder, such as Fiber Detox, which is a product with high fiber content, which helps in the digestive system. Its subsidiaries include DOD Healthy Life Co., Ltd., Ultima Life Co., Ltd., HY DOD Co., Ltd., and DOD Sale power Co., Ltd.
See Also
What is DOD Biotech PCL's Total Liabilities & Equity?
Total Liabilities & Equity
1.2B
THB
Based on the financial report for Sep 30, 2024, DOD Biotech PCL's Total Liabilities & Equity amounts to 1.2B THB.
What is DOD Biotech PCL's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-6%
Over the last year, the Total Liabilities & Equity growth was -15%. The average annual Total Liabilities & Equity growth rates for DOD Biotech PCL have been -8% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
